Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural low-dose esketamine for prevention of shivering after spinal anesthesia during cesarean section
ChiCTR2200060617Phase 4Not yet recruiting
- Sponsor
- Third People's Hospital of Xuzhou
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postanesthetic shivering (PAS), postoperative pain and postpartum depression (PPD) (2 arms), sponsored by Third People's Hospital of Xuzhou. Primary endpoint: Shivering level. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postanesthetic shivering (PAS)postoperative painpostpartum depression (PPD)
Beyond the preview
Go deeper on ChiCTR2200060617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060617.